Stephane Argivier joins MIP Diagnostics as Chief Licensing Officer
MIP Diagnostics Ltd. is delighted to announce the appointment of Stephane Argivier as Chief Licensing Officer to further support the delivery of our ambitious growth strategy.
He will bring his commercial and technical expertise to drive the adoption of MIPs in various market applications. This will include areas such as Bioprocessing for Therapeutics, Food and Beverage; Oil & Gas and Fundamental Research.
Stephane has over 22 years of experience in the Life Sciences and Diagnostics sectors with a track record of delivering fast growth with business entities ranging from start-ups to multinationals. He has won several business accolades in previous roles such as The Queen’s Awards for International Trade and for Innovation.
CEO of MIP Diagnostics Ltd., Dr Adrian Kinkaid, said: “I am delighted to have Stephane join the team and to be working with him to deliver the ambitious commercial plans for this remarkable technology.”
Chairman of MIP Diagnostics Ltd., Jim Reid, said: "We are delighted to welcome Stephane to the company. It is a testament to the progress MIP is making as a business that we can attract people of Stephane's undoubted quality. We look forward to major developments in our international activities and to progressing with the industrialisation of our strong technology portfolio."
Stephane Argivier said: "I am honoured and excited to be joining MIP as the new Chief Licensing Officer. I look forward to working with the team to help customers achieve their goals and push new boundaries by adopting this new and exciting technology.”
Stephane Argivier joins MIP Diagnostics